This is well reflected in the lung cancer data analyzed here (Fig. 6) wherein there is an upregulation of ALDH1A1; however, with a significant downregulation of RA-responsive genes, possibly owing to the elevated levels of PRMT3. The gene discussed is ALDH1A1; the disease is lung carcinoma.